These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 38139227)
1. Jacalin-Curcumin Complex Sensitizes the Breast Cancer MDA-MB-231 Cell Line. Petrova L; Gergov N; Stoup M; Zapryanova S; Van Damme EJM; Lebègue N; Liberelle M; Zasheva D; Bogoeva V Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139227 [TBL] [Abstract][Full Text] [Related]
2. The Curcumin Analog PAC Is a Potential Solution for the Treatment of Triple-Negative Breast Cancer by Modulating the Gene Expression of DNA Repair Pathways. Almalki E; Al-Amri A; Alrashed R; Al-Zharani M; Semlali A Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298600 [TBL] [Abstract][Full Text] [Related]
3. New bis(hydroxymethyl) alkanoate curcuminoid derivatives exhibit activity against triple-negative breast cancer in vitro and in vivo. Hsieh MT; Chang LC; Hung HY; Lin HY; Shih MH; Tsai CH; Kuo SC; Lee KH Eur J Med Chem; 2017 May; 131():141-151. PubMed ID: 28319780 [TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor (TLR) gene expression and immunostimulatory effect of CpG oligonucleotides in hormone receptor positive cell line T47D and triple negative breast cancer cell line MDA-MB-468. Natarajan S; Ranganathan M Immunopharmacol Immunotoxicol; 2020 Oct; 42(5):408-415. PubMed ID: 32686546 [TBL] [Abstract][Full Text] [Related]
5. Photodynamic treatment with anionic nanoclays containing curcumin on human triple-negative breast cancer cells: Cellular and biochemical studies. Khorsandi K; Hosseinzadeh R; Shahidi FK J Cell Biochem; 2019 Apr; 120(4):4998-5009. PubMed ID: 30302810 [TBL] [Abstract][Full Text] [Related]
6. Effect of bis(hydroxymethyl) alkanoate curcuminoid derivative MTH-3 on cell cycle arrest, apoptotic and autophagic pathway in triple-negative breast adenocarcinoma MDA-MB-231 cells: An in vitro study. Chang LC; Hsieh MT; Yang JS; Lu CC; Tsai FJ; Tsao JW; Chiu YJ; Kuo SC; Lee KH Int J Oncol; 2018 Jan; 52(1):67-76. PubMed ID: 29138806 [TBL] [Abstract][Full Text] [Related]
7. Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells. Thulasiraman P; McAndrews DJ; Mohiudddin IQ BMC Cancer; 2014 Sep; 14():724. PubMed ID: 25260874 [TBL] [Abstract][Full Text] [Related]
8. Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-kappaBp65 expression in breast cancer MDA-MB-231 cells. Chiu TL; Su CC Int J Mol Med; 2009 Apr; 23(4):469-75. PubMed ID: 19288022 [TBL] [Abstract][Full Text] [Related]
9. Ultra-microsecond pulsed curcumin for effective treatment of triple negative breast cancers. Mittal L; Raman V; Camarillo IG; Sundararajan R Biochem Biophys Res Commun; 2017 Sep; 491(4):1015-1020. PubMed ID: 28780353 [TBL] [Abstract][Full Text] [Related]
10. Activation of autophagy promotes the inhibitory effect of curcumin analog EF-24 against MDA-MB-231 cancer cells. Zhao YY; Li J; Wang HQ; Zheng HB; Ma SW; Zhou GZ J Biochem Mol Toxicol; 2024 Feb; 38(2):e23642. PubMed ID: 38348710 [TBL] [Abstract][Full Text] [Related]
11. Curcumin Inhibits the PPARδ-p-Akt-GLUT1 Pathway and Ameliorates the Antiproliferative Effects of Doxorubicin in MDA-MB-231 Cells. Thulasiraman P; Foret M; Pandit R; McAlister K Asian Pac J Cancer Prev; 2024 Mar; 25(3):1035-1043. PubMed ID: 38546086 [TBL] [Abstract][Full Text] [Related]
12. Apoptotic Effect of Gemini Curcumin on MDA-MB-468 Breast Cancer Cell Line. Hajizadeh M; Ghoran SH; Azeez HJ; Feizi MAH; Babaei E Anticancer Agents Med Chem; 2022; 22(11):2181-2188. PubMed ID: 34773965 [TBL] [Abstract][Full Text] [Related]
13. Nanoformulation of Polyphenol Curcumin Enhances Cisplatin-Induced Apoptosis in Drug-Resistant MDA-MB-231 Breast Cancer Cells. Karami P; Othman G; Housein Z; Salihi A; Hosseinpour Feizi MA; Azeez HJ; Babaei E Molecules; 2022 May; 27(9):. PubMed ID: 35566271 [TBL] [Abstract][Full Text] [Related]
14. Effective electrochemotherapy with curcumin in MDA-MB-231-human, triple negative breast cancer cells: A global proteomics study. Mittal L; Aryal UK; Camarillo IG; Raman V; Sundararajan R Bioelectrochemistry; 2020 Feb; 131():107350. PubMed ID: 31518962 [TBL] [Abstract][Full Text] [Related]
15. Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development. Tilli TM; Carels N; Tuszynski JA; Pasdar M Oncotarget; 2016 Sep; 7(39):63189-63203. PubMed ID: 27527857 [TBL] [Abstract][Full Text] [Related]
16. PLGA-CTAB curcumin nanoparticles: Fabrication, characterization and molecular basis of anticancer activity in triple negative breast cancer cell lines (MDA-MB-231 cells). Meena R; Kumar S; Kumar R; Gaharwar US; Rajamani P Biomed Pharmacother; 2017 Oct; 94():944-954. PubMed ID: 28810532 [TBL] [Abstract][Full Text] [Related]
17. Curcumin suppresses 4-hydroxytamoxifen resistance in breast cancer cells by targeting SLUG/Hexokinase 2 pathway. Geng C; Li J; Ding F; Wu G; Yang Q; Sun Y; Zhang Z; Dong T; Tian X Biochem Biophys Res Commun; 2016 Apr; 473(1):147-153. PubMed ID: 27012210 [TBL] [Abstract][Full Text] [Related]
18. 1-Chromonyl-5-Imidazolylpentadienone Demonstrates Anti-Cancer Action against TNBC and Exhibits Synergism with Paclitaxel. Modi K; Lawson S; Chen G; Tumuluri D; Rekhtman I; Kurtz M; Brailoiu GC; Chen QH; Lakshmikuttyamma A Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32806551 [TBL] [Abstract][Full Text] [Related]
19. Dendrosomal nanocurcumin and exogenous p53 can act synergistically to elicit anticancer effects on breast cancer cells. Baghi N; Bakhshinejad B; Keshavarz R; Babashah S; Sadeghizadeh M Gene; 2018 Sep; 670():55-62. PubMed ID: 29753810 [TBL] [Abstract][Full Text] [Related]
20. Characterization of HJ-PI01 as a novel Pim-2 inhibitor that induces apoptosis and autophagic cell death in triple-negative human breast cancer. Zhao YQ; Yin YQ; Liu J; Wang GH; Huang J; Zhu LJ; Wang JH Acta Pharmacol Sin; 2016 Sep; 37(9):1237-50. PubMed ID: 27397540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]